Trulieve Cannabis (TSE:TRU) Upgraded to “Moderate Buy” at Cormark

Trulieve Cannabis (TSE:TRU) was upgraded by equities researchers at Cormark from a “hold” rating to a “moderate buy” rating in a note issued to investors on Monday,Zacks.com reports.

Other equities research analysts have also issued research reports about the company. Craig Hallum upgraded Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th. Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a report on Monday, December 9th.

Trulieve Cannabis Stock Performance

Insiders Place Their Bets

In related news, Senior Officer Wes Getman purchased 9,500 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average price of C$7.02 per share, with a total value of C$66,702.35.

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.